The Effect of Leucine Restriction on Akt/mTOR Signaling in Breast Cancer Cell Lines In Vitro and In Vivo

REFERENCES

• Blommaart , E F , Luiken , J J , Blommaart , P J , van Woerkom , G M and Meijer , A J . 1995 . Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes . J Biol Chem , 270 : 2320 – 2326 .
   PubMed Web of Science ®Google Scholar
• Hara , K , Yonezawa , K , Weng , Q P , Kozlowski , M T Belham , C . 1998 . Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism . J Biol Chem , 273 : 14484 – 14494 .
   PubMed Web of Science ®Google Scholar
• Um , S H , D’Alessio , D and Thomas , G . 2006 . Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1 . Cell Metab , 3 : 393 – 402 .
   PubMed Web of Science ®Google Scholar
• Wang , X , Campbell , L E , Miller , C M and Proud , C G . 1998 . Amino acid availability regulates p70 S6 kinase and multiple translation factors . Biochem J , 334 ( Pt 1 ) : 261 – 267 .
   Google Scholar
• Corradetti , M N and Guan , K L . 2006 . Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? . Oncogene , 25 : 6347 – 6360 .
   PubMed Web of Science ®Google Scholar
• Liaw , D , Marsh , D J , Li , J , Dahia , P L Wang , S I . 1997 . Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome . Nat Genet , 16 : 64 – 67 .
   PubMed Web of Science ®Google Scholar
• Zhou , B P , Hu , M C , Miller , S A , Yu , Z Xia , W . 2000 . HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway . J Biol Chem , 275 : 8027 – 8031 .
   PubMedGoogle Scholar
• Cui , X , Zhang , P , Deng , W , Oesterreich , S Lu , Y . 2003 . Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer . Mol Endocrinol , 17 : 575 – 588 .
   PubMed Web of Science ®Google Scholar
• Mills , G B , Lu , Y , Fang , X , Wang , H Eder , A . 2001 . The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy . Semin Oncol , 28 : 125 – 141 .
   PubMed Web of Science ®Google Scholar
• Barlund , M , Forozan , F , Kononen , J , Bubendorf , L Chen , Y . 2000 . Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis . J Natl Cancer Inst , 92 : 1252 – 1259 .
   PubMed Web of Science ®Google Scholar
• Zhou , X , Tan , M , Stone Hawthorne , V , Klos , K S Lan , K H . 2004 . Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers . Clin Cancer Res , 10 : 6779 – 6788 .
   PubMed Web of Science ®Google Scholar
• Meric-Bernstam , F and Gonzalez-Angulo , A M . 2009 . Targeting the mTOR signaling network for cancer therapy . J Clin Oncol , 27 : 2278 – 2287 .
   PubMed Web of Science ®Google Scholar
• Chan , S , Scheulen , M E , Johnston , S , Mross , K Cardoso , F . 2005 . Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer . J Clin Oncol , 23 : 5314 – 5322 .
   PubMed Web of Science ®Google Scholar
• Ellard , S L , Clemons , M , Gelmon , K A , Norris , B Kennecke , H . 2009 . Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163 . J Clin Oncol , 27 : 4536 – 4541 .
   PubMed Web of Science ®Google Scholar
• Wullschleger , S , Loewith , R and Hall , M N . 2006 . TOR signaling in growth and metabolism . Cell , 124 : 471 – 484 .
   PubMed Web of Science ®Google Scholar
• Holz , M K , Ballif , B A , Gygi , S P and Blenis , J . 2005 . mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events . Cell , 123 : 569 – 580 .
   PubMed Web of Science ®Google Scholar
• Richter , J D and Sonenberg , N . 2005 . Regulation of cap-dependent translation by eIF4E inhibitory proteins . Nature , 433 : 477 – 480 .
   PubMed Web of Science ®Google Scholar
• Easton , J B and Houghton , P J . 2006 . mTOR and cancer therapy . Oncogene , 25 : 6436 – 6446 .
   PubMed Web of Science ®Google Scholar
• Inoki , K , Ouyang , H , Li , Y and Guan , K L . 2005 . Signaling by target of rapamycin proteins in cell growth control . Microbiol Mol Biol Rev , 69 : 79 – 100 .
   PubMed Web of Science ®Google Scholar
• Dilling , M B , Dias , P , Shapiro , D N , Germain , G S , Johnson , R K and Houghton , P J . 1994 . Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor . Cancer Res , 54 : 903 – 907 .
   PubMed Web of Science ®Google Scholar
• Noh , W C , Mondesire , W H , Peng , J , Jian , W Zhang , H . 2004 . Determinants of rapamycin sensitivity in breast cancer cells . Clin Cancer Res , 10 : 1013 – 1023 .
   PubMed Web of Science ®Google Scholar
• Hosoi , H , Dilling , M B , Shikata , T , Liu , L N Shu , L . 1999 . Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells . Cancer Res , 59 : 886 – 894 .
   PubMed Web of Science ®Google Scholar
• Huang , S , Liu , L N , Hosoi , H , Dilling , M B Shikata , T . 2001 . p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin . Cancer Res , 61 : 3373 – 3381 .
   PubMed Web of Science ®Google Scholar
• Beuvink , I , Boulay , A , Fumagalli , S , Zilbermann , F Ruetz , S . 2005 . The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation . Cell , 120 : 747 – 759 .
   PubMed Web of Science ®Google Scholar
• Mondesire , W H , Jian , W , Zhang , H , Ensor , J Hung , M C . 2004 . Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells . Clin Cancer Res , 10 : 7031 – 7042 .
   PubMed Web of Science ®Google Scholar
• Jacinto , E , Loewith , R , Schmidt , A , Lin , S Ruegg , M A . 2004 . Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive . Nat Cell Biol , 6 : 1122 – 1128 .
   PubMed Web of Science ®Google Scholar
• Sarbassov , D D , Ali , S M , Kim , D H , Guertin , D A Latek , R R . 2004 . Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton . Curr Biol , 14 : 1296 – 1302 .
   PubMed Web of Science ®Google Scholar
• Akcakanat , A , Singh , G , Hung , M C and Meric-Bernstam , F . 2007 . Rapamycin regulates the phosphorylation of rictor . Biochem Biophys Res Commun , 362 : 330 – 333 .
   PubMed Web of Science ®Google Scholar
• Dibble , C C , Asara , J M and Manning , B D . 2009 . Characterization of rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1 . Mol Cell Biol , 29 : 5657 – 5670 .
   PubMed Web of Science ®Google Scholar
• Dann , S G , Selvaraj , A and Thomas , G . 2007 . mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes, and cancer . Trends Mol Med , 13 : 252 – 259 .
   PubMed Web of Science ®Google Scholar
• Huang , J , Dibble , C C , Matsuzaki , M and Manning , B D . 2008 . The TSC1-TSC2 complex is required for proper activation of mTOR complex 2 . Mol Cell Biol , 28 : 4104 – 4115 .
   PubMed Web of Science ®Google Scholar
• Kimball , S R and Jefferson , L S . 2006 . New functions for amino acids: effects on gene transcription and translation . Am J Clin Nutr , 83 : 500S – 507S .
   PubMed Web of Science ®Google Scholar
• Kimball , S R , Shantz , L M , Horetsky , R L and Jefferson , L S . 1999 . Leucine regulates translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal protein S6 . J Biol Chem , 274 : 11647 – 11652 .
   PubMed Web of Science ®Google Scholar
• Hernandez-Negrete , I , Carretero-Ortega , J , Rosenfeldt , H , Hernandez-Garcia , R Calderon-Salinas , J V . 2007 . P-Rex1 links mammalian target of rapamycin signaling to Rac activation and cell migration . J Biol Chem , 282 : 23708 – 23715 .
   PubMed Web of Science ®Google Scholar
• Peng , T , Golub , T R and Sabatini , D M . 2002 . The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation . Mol Cell Biol , 22 : 5575 – 5584 .
   PubMed Web of Science ®Google Scholar
• Mordier , S , Deval , C , Bechet , D , Tassa , A and Ferrara , M . 2000 . Leucine limitation induces autophagy and activation of lysosome-dependent proteolysis in C2C12 myotubes through a mammalian target of rapamycin-independent signaling pathway . J Biol Chem , 275 : 29900 – 29906 .
   PubMed Web of Science ®Google Scholar
• Wasa , M , Bode , B P and Souba , W W . 1996 . Adaptive regulation of amino acid transport in nutrient-deprived human hepatomas . Am J Surg , 171 : 163 – 169 .
   Google Scholar
• Averous , J , Maurin , A C , Bruhat , A , Jousse , C Arliguie , C . 2005 . Induction of IGFBP-1 expression by amino acid deprivation of HepG2 human hepatoma cells involves both a transcriptional activation and an mRNA stabilization due to its 3′UTR . FEBS Lett , 579 : 2609 – 2614 .
   Google Scholar
• Anthony , T G , McDaniel , B J , Byerley , R L , McGrath , B C Cavener , D R . 2004 . Preservation of liver protein synthesis during dietary leucine deprivation occurs at the expense of skeletal muscle mass in mice deleted for eIF2 kinase GCN2 . J Biol Chem , 279 : 36553 – 36561 .
   PubMed Web of Science ®Google Scholar
• Kim , M S , Wu , K Y , Auyeung , V , Chen , Q Gruppuso , P A . 2009 . Leucine restriction inhibits chondrocyte proliferation and differentiation through mechanisms both dependent and independent of mTOR signaling . Am J Physiol Endocrinol Metab , 296 : E1374 – E1382 .
   Google Scholar
• Avruch , J , Long , X , Ortiz-Vega , S , Rapley , J , Papageorgiou , A and Dai , N . 2009 . Amino acid regulation of TOR complex 1 . Am J Physiol Endocrinol Metab , 296 : E592 – E602 .
   PubMed Web of Science ®Google Scholar
• Lee , M Y , Jo , S D , Lee , J H and Han , H J . 2008 . L-leucine increases [3H]-thymidine incorporation in chicken hepatocytes: involvement of the PKC, PI3K/Akt, ERK1/2, and mTOR signaling pathways . J Cell Biochem , 105 : 1410 – 1419 .
   Google Scholar
• O’Reilly , K E , Rojo , F , She , Q B , Solit , D Mills , G B . 2006 . mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt . Cancer Res , 66 : 1500 – 1508 .
   PubMed Web of Science ®Google Scholar
• Sarbassov , D D , Guertin , D A , Ali , S M and Sabatini , D M . 2005 . Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex . Science , 307 : 1098 – 101 .
   PubMed Web of Science ®Google Scholar
• Sarbassov , D D , Ali , S M , Sengupta , S , Sheen , J H Hsu , P P . 2006 . Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB . Mol Cell , 22 : 159 – 168 .
   PubMed Web of Science ®Google Scholar
• Harrington , L S , Findlay , G M , Gray , A , Tolkacheva , T Wigfield , S . 2004 . The TSC1–2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins . J Cell Biol , 166 : 213 – 223 .
   PubMed Web of Science ®Google Scholar
• Manning , B D , Tee , A R , Logsdon , M N , Blenis , J and Cantley , L C . 2002 . Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway . Mol Cell , 10 : 151 – 162 .
   PubMed Web of Science ®Google Scholar
• Um , S H , Frigerio , F , Watanabe , M , Picard , F Joaquin , M . 2004 . Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity . Nature , 431 : 200 – 205 .
   PubMed Web of Science ®Google Scholar
• Brazil , D P and Hemmings , B A . 2001 . Ten years of protein kinase B signalling: a hard Akt to follow . Trends Biochem Sci , 26 : 657 – 664 .
   PubMed Web of Science ®Google Scholar
• Kimball , S R and Jefferson , L S . 2004 . Molecular mechanisms through which amino acids mediate signaling through the mammalian target of rapamycin . Curr Opin Clin Nutr Metab Care , 7 : 39 – 44 .
   PubMedGoogle Scholar
• Ban , H , Shigemitsu , K , Yamatsuji , T , Haisa , M Nakajo , T . 2004 . Arginine and Leucine regulate p70 S6 kinase and 4E-BP1 in intestinal epithelial cells . Int J Mol Med , 13 : 537 – 543 .
   Web of Science ®Google Scholar
• Dhar , R and Basu , A . 2008 . Constitutive activation of p70 S6 kinase is associated with intrinsic resistance to cisplatin . Int J Oncol , 32 : 1133 – 1137 .
   PubMedGoogle Scholar
• Peyrollier , K , Hajduch , E , Blair , A S , Hyde , R and Hundal , H S . 2000 . L-leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the L-leucine-induced up-regulation of system A amino acid transport . Biochem J , 350 ( Pt 2 ) : 361 – 368 .
   Google Scholar
• Nicklin , P , Bergman , P , Zhang , B , Triantafellow , E Wang , H . 2009 . Bidirectional transport of amino acids regulates mTOR and autophagy . Cell , 136 : 521 – 534 .
   PubMed Web of Science ®Google Scholar
• Kokkinakis , D M , Brickner , A G , Kirkwood , J M , Liu , X Goldwasser , J E . 2006 . Mitotic arrest, apoptosis, and sensitization to chemotherapy of melanomas by methionine deprivation stress . Mol Cancer Res , 4 : 575 – 589 .
   PubMed Web of Science ®Google Scholar
• Scott , L , Lamb , J , Smith , S and Wheatley , D N . 2000 . Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells . Br J Cancer , 83 : 800 – 810 .
   PubMed Web of Science ®Google Scholar
• Tannenbaum , A and Silverstone , H . 1953 . Effect of limited food intake on survival of mice bearing spontaneous mammary carcinoma and on the incidence of lung metastases . Cancer Res , 13 : 532 – 536 .
   PubMedGoogle Scholar
• Thompson , H J , Zhu , Z and Jiang , W . 2003 . Dietary energy restriction in breast cancer prevention . J Mammary Gland Biol Neoplasia , 8 : 133 – 142 .
   PubMed Web of Science ®Google Scholar
• Zhu , Z , Haegele , A D and Thompson , H J . 1997 . Effect of caloric restriction on pre-malignant and malignant stages of mammary carcinogenesis . Carcinogenesis , 18 : 1007 – 1012 .
   PubMed Web of Science ®Google Scholar
• Kalaany , N Y and Sabatini , D M . 2009 . Tumours with PI3K activation are resistant to dietary restriction . Nature , 458 : 725 – 731 .
   PubMed Web of Science ®Google Scholar
• Raffaghello , L , Lee , C , Safdie , F M , Wei , M Madia , F . 2008 . Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy . Proc Natl Acad Sci USA , 105 : 8215 – 8220 .
   PubMed Web of Science ®Google Scholar